Intra‐ and inter‐tumor heterogeneity in a vemurafenib‐resistant melanoma patient and derived xenografts

E-ISSN： 1757-4684|7|9|1104-1118

ISSN： 1757-4676

Source： EMBO Molecular Medicine, Vol.7, Iss.9, 2015-09, pp. : 1104-1118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spatial intra‐tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co‐clinical cancer studies

EMBO Molecular Medicine, Vol. 7, Iss. 9, 2015-09 ,pp. : 1087-1089

John Wiley & Sons Inc

Access to resources Recommend Favorite

Validation and Inter-Comparison of Spaceborne Derived Global and Continental Land Cover Products for the Mediterranean Region: The Case of Thessaly

By Manakos Ioannis Karakizi Christina Gkinis Ioannis Karantzalos Konstantinos

Land, Vol. 6, Iss. 2, 2017-05 ,pp. : 34-34

MDPI

Access to resources Recommend Favorite

Inhibition of JAK2/STAT3 reduces tumor‐induced angiogenesis and myeloid‐derived suppressor cells in head and neck cancer

Molecular Carcinogenesis, Vol. 57, Iss. 3, 2018-03 ,pp. : 429-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction of the proapoptotic tumor suppressor gene Cell Adhesion Molecule 1 by chemotherapeutic agents is repressed in therapy resistant acute myeloid leukemia

Molecular Carcinogenesis, Vol. 54, Iss. 12, 2015-12 ,pp. : 1815-1819

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pitfalls in diagnosis with the use of circulating tumor‐derived epidermal growth factor receptor mutations in lung cancer harboring pretreatment T790M

Thoracic Cancer, Vol. 9, Iss. 1, 2018-01 ,pp. : 171-174

John Wiley & Sons Inc

Access to resources Recommend Favorite